Unraveling the Potential Role of Tecomella undulatain Experimental NASH

Author:

Srinivas Akshatha N.ORCID,Suresh Diwakar,Suvarna Deepak,Pathak Pankaj,Giri Suresh,Suman ,Satish Suchitha,Chidambaram Saravana BabuORCID,Kumar Divya P.ORCID

Abstract

ABSTRACTBackground and AimThe pathophysiology of NASH is complex owing to its diverse pathological drivers, and until recently, there were no approved drugs for this disease.Tecomella undulatais a popular herbal medicine used to treat hepatosplenomegaly, hepatitis, and obesity. However, the potential role ofTecomella undulatain NASH has not yet been scientifically investigated.Experimental ProcedureMice fed with chow diet and normal water (CDNW) or western diet and sugar water (WDSW) for 12 weeks were randomized to receive vehicle control, Saroglitazar, orTecomella undulatafor an additional 12 weeks. Insulin resistance, lipid profiles, histological analysis, and liver enzymes were assessed. The oxidative stress, ER and inflammatory markers were determined by quantitative RT-PCR (qRT-PCR) and western blot analysis.Results and ConclusionThe administration ofTecomella undulatavia oral gavage lowered body weight, insulin resistance, alanine transaminase (ALT), aspartate transaminase (AST), triglycerides, and total cholesterol in WDSW mice but had no effect on CDNW mice.Tecomella undulataimproved steatosis, lobular inflammation, and hepatocyte ballooning and resolved NASH in WDSW mice. Furthermore,Tecomella undulataalso alleviated the WDSW-induced ER stress and oxidative stress, enhanced antioxidant status, and thus reduced inflammation in the treated mice. Of note, these effects were on par with Saroglitazar, the approved drug used to treat human NASH and positive control used in the study.Thus, our findings indicate the potential ofTecomella undulatato ameliorate WDSW-induced steatohepatitis, and these preclinical data provide a strong rationale for assessingTecomella undulatafor the treatment of NASH in humans.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3